Auromedics Pharma

Argatroban

Manufacturer:

Auromedics Pharma

Argatroban HCPCS:

J0899

HCPCS Code Descriptor:

Injection, argatroban (auromedics), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)

Category:

J Code

Argatroban NDCs:

55150-0241-01, 55150-0241-10

Primary Type:

Anti-coagulant

Generic/Specialty Status:

Single-Source

Package Type:

Not Found

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

55150-0241-01, 55150-0241-10

About Argatroban:

Argatroban is an Anti-coagulant drug manufactured by Auromedics Pharma and administered via the Intravenous route of administration. The J Code: J0899 is aligned to the drug Argatroban.

ACCESS PRICING AND MORE BY REGISTERING

J0899 Added Date:

January 1, 2023

J0899 Effective Date:

April 1, 2023

J0899 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Argatroban billing and coding information.
Our team did not identify a source for Argatroban patient assistance information. Please reach out to our team if you feel that this is a mistake.
Argatroban prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for Argatroban. Please check back in a few weeks.